Immunic, Inc.
IMUX· Nasdaq
Released Nov 13, 2025, before the open
10-Q filed Nov 13, 2025, 44 days after period end · 0001280776-25-000017
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$25.58M | -$24.37M | -$22.77M | -$21.22M |
| EPS Diluted | -$1.32 | -$0.24 | -$0.51 | -$0.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR